Mice Model Market Overview
The Mice Model Market is experiencing robust growth driven by technological advancements in genetic engineering, increasing demand for personalized medicine, and expanding applications in biomedical research. Mice models remain essential tools for disease modeling, drug discovery, preclinical testing, and the development of targeted therapies.
According to the latest Market Research Future report, updated August 27, 2026, the Mice Model Market was valued at USD 1.677 billion in 2024 and is projected to grow from USD 1.781 billion in 2025 to USD 3.251 billion by 2035, registering a CAGR of 6.2% during the forecast period 2025–2035. North America remains the largest regional market, accounting for approximately 45% of the global share, while Asia-Pacific is emerging as the fastest-growing region. Genetically Engineered Mice represent the largest model type segment, while Inbred Mice are witnessing the fastest growth. Drug Discovery & Development recorded the highest valuation among applications in 2024 at USD 0.8 billion.
Unlock Exclusive Insights – Request Your Free Sample Report Now!
https://www.marketresearchfuture.com/sample_request/21972
Key players driving innovation and competitiveness in the Mice Model Market include:
Charles River Laboratories
The Jackson Laboratory
Taconic Biosciences
Envigo
Harlan Laboratories
Crown Bioscience
Janvier Labs
InVivo Biosystems
GenOway
The Mice Model Market is being propelled by rising demand for drug discovery and increasing investment in cancer and biomedical research. Advancements in genetic engineering, including CRISPR/CAS9, are enabling the development of precise models that better replicate human diseases. Growing emphasis on personalized medicine is also increasing demand for genetically modified models that reflect specific genetic variations. In addition, regulatory support, expanding research funding, and technological advancements in gene editing and imaging are strengthening market opportunities.
The Mice Model Market can be segmented by Model Type & Service, Technology, Therapeutic Area, Application, End User, and Region. By Model Type, Genetically Engineered Mice dominate, while Inbred Mice are the fastest-growing segment. By Service, Breeding holds the largest position, while Cryopreservation is experiencing rapid growth. By Technology, CRISPR/CAS9 dominates, while Microinjection is the fastest-growing category. By Therapeutic Area, Oncology represents the largest segment, while Immunology is emerging rapidly. By Application, Drug Discovery & Development holds the largest share, while Personalized Medicine is the fastest-growing segment. By End User, Pharmaceutical & Biotechnology Companies dominate, while Academic & Research Institutes are witnessing the fastest growth.
Significant opportunities are emerging from the development of genetically modified mouse models for specific diseases, expansion of contract research organizations offering specialized mice model services, and integration of artificial intelligence into research and data analysis. Growing demand for personalized medicine, rare disease research, and advanced preclinical models is creating additional opportunities. Strategic partnerships between pharmaceutical companies, biotechnology firms, academic institutions, and model providers are also expected to support innovation and market expansion.
Recent Developments and Market Trends:
Advancements in genetic engineering are enabling the creation of increasingly precise and disease-relevant mice models for biomedical research.
CRISPR/CAS9 technology is transforming model development by enabling targeted genetic modifications and accelerating the generation of knock-out and knock-in models.
Personalized medicine is increasing demand for models capable of reflecting individual genetic variations and disease states.
Alternative research models, including organoids and humanized mice, are gaining attention as complementary approaches to traditional animal models.
Digitalization, sustainability, artificial intelligence, and strategic collaborations are becoming increasingly important in the competitive mice model landscape.
Reasons to Buy the Report:
Gain detailed insights into the global Mice Model Market size, growth trajectory, and forecast through 2035.
Understand major market segments across model type, service, technology, therapeutic area, application, and end-user categories.
Evaluate the competitive landscape and strategies of leading companies operating in the Mice Model Market.
Analyze key market drivers, technological advancements, emerging trends, and growth opportunities.
Assess regional market dynamics and identify opportunities across North America, Europe, Asia-Pacific, South America, and the Middle East and Africa.
Future Outlook:
The Mice Model Market is projected to grow at a CAGR of 6.2% from 2025 to 2035, reaching approximately USD 3.251 billion by 2035. North America is expected to retain its position as the largest regional market, supported by strong research and development activities, biotechnology investments, advanced healthcare infrastructure, and demand for genetically modified models. Europe remains the second-largest market, while Asia-Pacific is expected to maintain its position as the fastest-growing region due to increasing biotechnology and pharmaceutical research investments, expanding research institutions, and favorable government initiatives. Genetically Engineered Mice are expected to maintain their dominant position among model types, while Inbred Mice are projected to grow from USD 0.335 billion in 2024 to USD 0.65 billion by 2035. Breeding is expected to remain the leading service category, supported by demand for genetically specific and customized models, while Cryopreservation continues to gain importance for long-term genetic material storage. CRISPR/CAS9 is likely to remain the dominant technology, with Microinjection showing strong growth due to its accessibility and adaptability. Oncology is expected to remain the leading therapeutic area, while Immunology benefits from increasing autoimmune disease and immunotherapy research. Drug Discovery & Development is projected to continue leading applications, while Personalized Medicine emerges as an important growth area. Pharmaceutical & Biotechnology Companies are expected to remain the largest end-user group, with Academic & Research Institutes projected to experience strong growth. Overall, advances in genetic engineering, personalized medicine, AI-enabled research, and specialized preclinical models are expected to support the continued expansion of the Mice Model Market through 2035.
➤➤Explore Our Latest Related Reports:
